
### [NCIT:C7343](http://purl.obolibrary.org/obo/NCIT_C7343)
**Label:** Benign Cutaneous Fibrohistiocytic Neoplasm

**Subclasses:** [NCIT:C6801](http://purl.obolibrary.org/obo/NCIT_C6801) (Cutaneous Fibrous Histiocytoma), [NCIT:C49078](http://purl.obolibrary.org/obo/NCIT_C49078) (Cutaneous Fibrous Histiocytoma, Cellular Variant), [NCIT:C49076](http://purl.obolibrary.org/obo/NCIT_C49076) (Cutaneous Fibrous Histiocytoma, Fibroblastic Variant), 

**Class expressions from DL-Learner:**

- Thing 52.89%
- [CL:0000864](http://purl.obolibrary.org/obo/CL_0000864) (tissue-resident macrophage) 39.20%
- [CL:0000864](http://purl.obolibrary.org/obo/CL_0000864) (tissue-resident macrophage) and (not ([NCIT:C40114](http://purl.obolibrary.org/obo/NCIT_C40114) (Fallopian Tube Serous Cystadenofibroma))) 39.20%
- [CL:0000864](http://purl.obolibrary.org/obo/CL_0000864) (tissue-resident macrophage) and (not ([NCIT:C40112](http://purl.obolibrary.org/obo/NCIT_C40112) (Fallopian Tube Papilloma))) 39.20%
- [CL:0000864](http://purl.obolibrary.org/obo/CL_0000864) (tissue-resident macrophage) and (not ([NCIT:C40110](http://purl.obolibrary.org/obo/NCIT_C40110) (Borderline Fallopian Tube Endometrioid Tumor))) 39.20%
- [CL:0000864](http://purl.obolibrary.org/obo/CL_0000864) (tissue-resident macrophage) and (not ([NCIT:C40108](http://purl.obolibrary.org/obo/NCIT_C40108) (Borderline Fallopian Tube Mucinous Tumor))) 39.20%
- [CL:0000864](http://purl.obolibrary.org/obo/CL_0000864) (tissue-resident macrophage) and (not ([NCIT:C40107](http://purl.obolibrary.org/obo/NCIT_C40107) (Borderline Fallopian Tube Serous Tumor/Atypical Proliferative Serous Tumor))) 39.20%
- [CL:0000864](http://purl.obolibrary.org/obo/CL_0000864) (tissue-resident macrophage) and (not ([NCIT:C40104](http://purl.obolibrary.org/obo/NCIT_C40104) (Fallopian Tube Transitional Cell Carcinoma))) 39.20%
- [CL:0000864](http://purl.obolibrary.org/obo/CL_0000864) (tissue-resident macrophage) and (not ([NCIT:C40103](http://purl.obolibrary.org/obo/NCIT_C40103) (Fallopian Tube Mucinous Adenocarcinoma))) 39.20%
- [CL:0000864](http://purl.obolibrary.org/obo/CL_0000864) (tissue-resident macrophage) and (not ([NCIT:C40093](http://purl.obolibrary.org/obo/NCIT_C40093) (Ovarian Squamous Cell Carcinoma))) 39.20%
- [CL:0000864](http://purl.obolibrary.org/obo/CL_0000864) (tissue-resident macrophage) and (not ([NCIT:C40090](http://purl.obolibrary.org/obo/NCIT_C40090) (Ovarian Seromucinous Carcinoma))) 39.20%
- [CL:0000864](http://purl.obolibrary.org/obo/CL_0000864) (tissue-resident macrophage) and (not ([NCIT:C40086](http://purl.obolibrary.org/obo/NCIT_C40086) (Ovarian Clear Cell Cystadenofibroma))) 39.20%
- [CL:0000864](http://purl.obolibrary.org/obo/CL_0000864) (tissue-resident macrophage) and (not ([NCIT:C40083](http://purl.obolibrary.org/obo/NCIT_C40083) (Borderline Ovarian Clear Cell Cystadenofibroma))) 39.20%
- [CL:0000864](http://purl.obolibrary.org/obo/CL_0000864) (tissue-resident macrophage) and (not ([NCIT:C40082](http://purl.obolibrary.org/obo/NCIT_C40082) (Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma))) 39.20%
- [CL:0000864](http://purl.obolibrary.org/obo/CL_0000864) (tissue-resident macrophage) and (not ([NCIT:C4008](http://purl.obolibrary.org/obo/NCIT_C4008) (Recurrent Gallbladder Carcinoma))) 39.20%


